🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a randomized, double-blind, placebo-controlled, superiority phase I...
Status
Completed
Location
UVA Health
Start Date
2021-05-25
Trial ID
NCT04920916
Primary Objective: To evaluate the effects of SAR440340 with or without du...
Status
Completed
Location
Investigational Site Number 8400026
Start Date
2018-03-12
Trial ID
NCT03387852
This study is researching a drug called dupilumab, referred to as "study dr...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-06-30
Trial ID
NCT07587658
This is parallel, Phase 4 study which consists of a 24 week (0.5 years) ran...
Status
Active Not Recruiting
Location
United Gastroenterologists - Murrieta- Site Number : 8400001
Start Date
2023-11-29
Trial ID
NCT06101095
Primary Objective: To evaluate the efficacy of dupilumab 300 mg every 2 we...
Status
Completed
Location
Investigational Site Number 8400019
Start Date
2016-11-28
Trial ID
NCT02898454
Treatments Being Tested
This study is a 2-part (parts A and B) phase 2/3 study to evaluate the safe...
Status
Completed
Location
Regeneron Investigational Site
Start Date
2017-11-30
Trial ID
NCT03346434
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability and pharm...
Status
Completed
Location
Shanghai Skin Disease Hospital
Start Date
2024-01-05
Trial ID
NCT06193434
Treatments Being Tested
To date, there are no effective therapy for the management of Netherton Syn...
Status
Unknown
Location
Dermatologie Necker
Start Date
2020-07-23
Trial ID
NCT04244006
Treatments Being Tested
The trial involves two interventions: (i) exposure to HDM in the ACC and (i...
Status
Active Not Recruiting
Location
Biogenics Research Chamber
Start Date
2023-03-29
Trial ID
NCT05720325
Treatments Being Tested
Primary Objective: To evaluate the efficacy of dupilumab as assessed by th...
Status
Completed
Location
Sacramento Ear, Nose & Throat Site Number : 8400010
Start Date
2020-12-02
Trial ID
NCT04678856
Treatments Being Tested